TLN1 and neoplasm: Recent studies have depicted that a small-molecule inhibitor (C67399) that blocks the interaction between talin1 and β1-integrin inhibits the tumor size and lung metastasis in vivo by interfering with the FA formation and migration in vitro may be a potential target for tumor therapy [19].